PFHO significantly reduced DED symptoms' severity and frequency within 14 days, with a 62% to 75% reduction in severity. Participants reported increased satisfaction with PFHO, describing it as silky, ...
Results from the OASIS 4 clinical trial show that a new drug, elinzanetant, relieved hot flashes and night sweats that can occur because of the menopause or because of hormone treatment for breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results